Prescription Practice of Prabchompootaweep Formulary for Allergic Rhinitis

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

TCTR

Registry ID

TCTR20170819001

Enrollment

Unknown

Registered

2017-08-19

Start date

2016-01-25

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic Rhinitis Allergic Rhinitis Plant Preparations Observational Study

Interventions

Patients received one 400mg capsule of Prabchompootaweep Formulary of 23 Thai herbs&#44

which is in the National List of Essential Medicine&#44

4 times per day for 7 days&#44

as an adjunct to the standard treatment of allergic rhinitis.

Supportive Care

Prabchompootaweep Formulary

Eligibility

Sex/Gender

All

Age

16 Years to No maximum

Inclusion criteria

Inclusion criteria: Adult and adolescent with allergic rhinitis symptoms

Exclusion criteria

Exclusion criteria: History of allergy to any of the herbs used in this study History of cancer of any kind

Design outcomes

Primary

Measure	Time frame
Allergic Rhinitis Condition Week 1 and 2 after treatment Number of capsules used	—

Secondary

Measure	Time frame
Side effects Week 1 and 2 after treatment Incidence	—

Countries

Thailand

Contacts

Public ContactJeeranun Boonim

Thai Traditional Medicine

nnojeeranun@hotmail.com0871620590

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026